Arrestin

S-antigen; retina and pineal gland (arrestin)

File:1CF1.png

Crystallographic structure of the bovine arrestin-S.[1]

Identifiers
Symbol| SAG
Alt. symbols| arrestin-1
Entrez| 6295
HUGO| 10521
OMIM| 181031
RefSeq| NM_000541
UniProt| P10523
Other data
Locus| Chr. 2 q37.1
arrestin beta 1

Identifiers
Symbol| ARRB1
Alt. symbols| ARR1, arrestin-2
Entrez| 408
HUGO| 711
OMIM| 107940
RefSeq| NM_004041
UniProt| P49407
Other data
Locus| Chr. 11 q13
arrestin beta 2

Identifiers
Symbol| ARRB2
Alt. symbols| ARR2, arrestin-3
Entrez| 409
HUGO| 712
OMIM| 107941
RefSeq| NM_004313
UniProt| P32121
Other data
Locus| Chr. 17 p13
arrestin 3, retinal (X-arrestin)

Identifiers
Symbol| ARR3
Alt. symbols| ARRX, arrestin-4
Entrez| 407
HUGO| 710
OMIM| 301770
RefSeq| NM_004312
UniProt| P36575
Other data
Locus| Chr. X q

Arrestins (abbreviated Arr) are a small family of proteins important for regulating signal transduction at G protein-coupled receptors.[2][3] Arrestins were first discovered as a part of a conserved two-step mechanism for regulating the activity of G protein-coupled receptors (GPCRs) in the visual rhodopsin system by Hermann Kühn, Scott Hall, and Ursula Wilden[4] and in the β-adrenergic system by Martin J. Lohse and co-workers.[5][6]

## Contents

* 1 Function
* 2 Subtypes
* 3 Tissue distribution
* 4 Mechanism
* 5 Structure
* 6 References
* 7 External links

## Function

[edit | edit source]

In response to a stimulus, GPCRs activate heterotrimeric G proteins. In order to turn off this response, or adapt to a persistent stimulus, active receptors need to be desensitized. The first step in desensitization is phosphorylation by a class of serine/threonine kinases called G protein coupled receptor kinases (GRKs). GRK phosphorylation specifically prepares the activated receptor for arrestin binding. Arrestin binding to the receptor blocks further G protein-mediated signaling and targets receptors for internalization, and redirects signaling to alternative G protein-independent pathways, such as β-arrestin signaling.[7][8][9][10][6] In addition to GPCRs, arrestins bind to other classes of cell surface receptors and a variety of other signaling proteins.[11]

## Subtypes

[edit | edit source]

Mammals express four arrestin subtypes and each arrestin subtype is known by multiple aliases. The systematic arrestin name (1-4) plus the most widely used aliases for each arrestin subtype are listed in bold below:

* Arrestin-1 was originally identified as the S-antigen (SAG) causing uveitis (autoimmune eye disease), then independently described as a 48 kDa protein that binds light-activated phosphorylated rhodopsin before it became clear that both are one and the same. It was later renamed visual arrestin, but when another cone-specific visual subtype was cloned the term rod arrestin was coined. This also turned out to be a misnomer: arrestin-1 expresses at comparable very high levels in both rod and cone photoreceptor cells.
* Arrestin-2 was the first non-visual arrestin cloned. It was first named β-arrestin simply because between two GPCRs available in purified form at the time, rhodopsin and β2-adrenergic receptor, it showed preference for the latter.
* Arrestin-3. The second non-visual arrestin cloned was first termed β-arrestin-2 (retroactively changing the name of β-arrestin into β-arrestin-1), even though by that time it was clear that non-visual arrestins interact with hundreds of different GPCRs, not just with β2-adrenergic receptor. Systematic names, arrestin-2 and arrestin-3, respectively, were proposed soon after that.
* Arrestin-4 was cloned by two groups and termed cone arrestin, after photoreceptor type that expresses it, and X-arrestin, after the chromosome where its gene resides. In the HUGO database its gene is called arrestin-3.

Fish and other vertebrates appear to have only three arrestins: no equivalent of arrestin-2, which is the most abundant non-visual subtype in mammals, was cloned so far. The proto-chordate C. intestinalis (sea squirt) has only one arrestin, which serves as visual in its mobile larva with highly developed eyes, and becomes generic non-visual in the blind sessile adult. Conserved positions of multiple introns in its gene and those of our arrestin subtypes suggest that they all evolved from this ancestral arrestin.[12] Lower invertebrates, such as roundworm C. elegans, also have only one arrestin. Insects have arr1 and arr2, originally termed “visual arrestins” because they are expressed in photoreceptors, and one non-visual subtype (kurtz in Drosophila). Later arr1 and arr2 were found to play an important role in olfactory neurons and renamed “sensory”. Fungi have distant arrestin relatives involved in pH sensing.

## Tissue distribution

[edit | edit source]

One or more arrestin is expressed in virtually every eukaryotic cell. In mammals, arrestin-1 and arrestin-4 are largely confined to photoreceptors, whereas arrestin-2 and arrestin-3 are ubiquitous. Neurons have the highest expression level of both non-visual subtypes. In neuronal precursors both are expressed at comparable levels, whereas in mature neurons arrestin-2 is present at 10-20 fold higher levels than arrestin-3.

## Mechanism

[edit | edit source]

Arrestins block GPCR coupling to G proteins in two ways. First, arrestin binding to the cytoplasmic face of the receptor occludes the binding site for heterotrimeric G-protein, preventing its activation (desensitization).[13] Second, arrestin links the receptor to elements of the internalization machinery, clathrin and clathrin adaptor AP2, which promotes receptor internalization via coated pits and subsequent transport to internal compartments, called endosomes. Subsequently, the receptor could be either directed to degradation compartments (lysosomes) or recycled back to the plasma membrane where it can again signal. The strength of arrestin-receptor interaction plays a role in this choice: tighter complexes tend to increase the probability of receptor degradation (Class B), whereas more transient complexes favor recycling (Class A), although this “rule” is far from absolute.[2]

## Structure

[edit | edit source]

Arrestins are elongated molecules, in which several intra-molecular interactions hold the relative orientation of the two domains. In unstimulated cell arrestins are localized in the cytoplasm in this basal “inactive” conformation. Active phosphorylated GPCRs recruit arrestin to the plasma membrane. Receptor binding induces a global conformational change that involves the movement of the two arrestin domains and the release of its C-terminal tail that contains clathrin and AP2 binding sites. Increased accessibility of these sites in receptor-bound arrestin targets the arrestin-receptor complex to the coated pit. Arrestins also bind microtubules (part of the cellular “skeleton”), where they assume yet another conformation, different from both free and receptor-bound form. Microtubule-bound arrestins recruit certain proteins to the cytoskeleton, which affects their activity and/or redirects it to microtubule-associated proteins.

Arrestins shuttle between cell nucleus and cytoplasm. Their nuclear functions are not fully understood, but it was shown that all four mammalian arrestin subtypes remove some of their partners, such as protein kinase JNK3 or the ubiquitin ligase Mdm2, from the nucleus. Arrestins also modify gene expression by enhancing transcription of certain genes.

| Arrestin (or S-antigen), N-terminal domain

File:PDB 1cf1 EBI.jpg

Structure of arrestin from bovine rod outer segments.[1]

Identifiers
Symbol| Arrestin_N
Pfam| PF00339
Pfam clan| CL0135
InterPro| IPR011021
PROSITE| PDOC00267
SCOP| 1cf1
SUPERFAMILY| 1cf1
| Available protein structures:

Pfam| structures
PDB| RCSB PDB; PDBe; PDBj
PDBsum| structure summary
| Arrestin (or S-antigen), C-terminal domain

File:PDB 1g4m EBI.jpg

Structure of bovine beta-arrestin.[14]

Identifiers
Symbol| Arrestin_C
Pfam| PF02752
Pfam clan| CL0135
InterPro| IPR011022
SCOP| 1cf1
SUPERFAMILY| 1cf1
| Available protein structures:

Pfam| structures
PDB| RCSB PDB; PDBe; PDBj
PDBsum| structure summary

## References

[edit | edit source]

1. ↑ 1.0 1.1 PDB: 1CF1​; Hirsch JA, Schubert C, Gurevich VV, Sigler PB (April 1999). "The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation". Cell. 97 (2): 257–69. doi:10.1016/S0092-8674(00)80735-7. PMID 10219246.
2. ↑ 2.0 2.1 Moore CA, Milano SK, Benovic JL (2007). "Regulation of receptor trafficking by GRKs and arrestins". Annual Review of Physiology. 69: 451–82. doi:10.1146/annurev.physiol.69.022405.154712. PMID 17037978.
3. ↑ Lefkowitz RJ, Shenoy SK (April 2005). "Transduction of receptor signals by beta-arrestins". Science. 308 (5721): 512–7. doi:10.1126/science.1109237. PMID 15845844.
4. ↑ Wilden U, Hall SW, Kühn H (March 1986). "Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments". Proceedings of the National Academy of Sciences of the United States of America. 83 (5): 1174–8. doi:10.1073/pnas.83.5.1174. PMC 323037. PMID 3006038.
5. ↑ Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ (June 1990). "beta-Arrestin: a protein that regulates beta-adrenergic receptor function". Science. 248 (4962): 1547–50. doi:10.1126/science.2163110. PMID 2163110.
6. ↑ 6.0 6.1 Gurevich VV, Gurevich EV (June 2006). "The structural basis of arrestin-mediated regulation of G-protein-coupled receptors". Pharmacology & Therapeutics. 110 (3): 465–502. doi:10.1016/j.pharmthera.2005.09.008. PMC 2562282. PMID 16460808.
7. ↑ Smith JS, Lefkowitz RJ, Rajagopal S (January 2018). "Biased signalling: from simple switches to allosteric microprocessors". Nature Reviews. Drug Discovery. doi:10.1038/nrd.2017.229. PMID 29302067.
8. ↑ Cahill TJ, Thomsen AR, Tarrasch JT, Plouffe B, Nguyen AH, Yang F, et al. (February 2017). "Distinct conformations of GPCR-β-arrestin complexes mediate desensitization, signaling, and endocytosis". Proceedings of the National Academy of Sciences of the United States of America. doi:10.1073/pnas.1701529114. PMC 5347553. PMID 28223524.
9. ↑ Kumari P, Srivastava A, Banerjee R, Ghosh E, Gupta P, Ranjan R, Chen X, Gupta B, Gupta C, Jaiman D, Shukla AK (November 2016). "Functional competence of a partially engaged GPCR-β-arrestin complex". Nature Communications. 7: 13416. doi:10.1038/ncomms13416. PMC 5105198. PMID 27827372.
10. ↑ Kumari P, Srivastava A, Ghosh E, Ranjan R, Dogra S, Yadav PN, Shukla AK (April 2017). "Core engagement with β-arrestin is dispensable for agonist-induced vasopressin receptor endocytosis and ERK activation". Molecular Biology of the Cell. 28 (8): 1003–10. doi:10.1091/mbc.E16-12-0818. PMC 5391177. PMID 28228552.
11. ↑ Gurevich VV, Gurevich EV (February 2004). "The molecular acrobatics of arrestin activation". Trends in Pharmacological Sciences. 25 (2): 105–11. doi:10.1016/j.tips.2003.12.008. PMID 15102497.
12. ↑ Gurevich EV, Gurevich VV (2006). "Arrestins: ubiquitous regulators of cellular signaling pathways". Genome Biology. 7 (9): 236. doi:10.1186/gb-2006-7-9-236. PMC 1794542. PMID 17020596.
13. ↑ Kang Y, Zhou XE, Gao X, He Y, Liu W, Ishchenko A, et al. (July 2015). "Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser". Nature. 523 (7562): 561–7. doi:10.1038/nature14656. PMC 4521999. PMID 26200343.
14. ↑ Han M, Gurevich VV, Vishnivetskiy SA, Sigler PB, Schubert C (September 2001). "Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation". Structure. 9 (9): 869–80. doi:10.1016/S0969-2126(01)00644-X. PMID 11566136.

## External links

[edit | edit source]

* Arrestin at the US National Library of Medicine Medical Subject Headings (MeSH)

* v
* t
* e

Protein: cell membrane proteins (other than Cell surface receptor, enzymes, and cytoskeleton)

Arrestin|

* SAG
* ARRB1
* ARRB2
* ARR3

Membrane-spanning 4A|

* MS4A1
* MS4A2
* MS4A3
* MS4A4A
* MS4A4E
* MS4A5
* MS4A6A
* MS4A6E
* MS4A7
* MS4A8B
* MS4A9
* MS4A10
* MS4A12
* MS4A13
* MS4A14
* MS4A15
* MS4A18

Myelin|

* Myelin basic protein
* PMP2
* Myelin proteolipid protein
* PLP1
* Myelin oligodendrocyte glycoprotein
* Myelin-associated glycoprotein
* Myelin protein zero

Pulmonary surfactant|

* Pulmonary surfactant-associated protein B
* Pulmonary surfactant-associated protein C

Tetraspanin|

* TSPAN1
* TSPAN2
* TSPAN3
* TSPAN4
* TSPAN5
* TSPAN6
* TSPAN7
* TSPAN8
* TSPAN9
* TSPAN10
* TSPAN11
* TSPAN12
* TSPAN13
* TSPAN14
* TSPAN15
* TSPAN16
* TSPAN17
* TSPAN18
* TSPAN19
* TSPAN20
* TSPAN21
* TSPAN22
* TSPAN23
* TSPAN24
* TSPAN25
* TSPAN26
* TSPAN27
* TSPAN28
* TSPAN29
* TSPAN30
* TSPAN31
* TSPAN32
* TSPAN33
* TSPAN34

Other/ungrouped|

* Calnexin
* LDL-receptor-related protein-associated protein
* Neurofibromin 2
* Presenilin
* PSEN1
* PSEN2
* HFE
* Phospholipid transfer proteins
* Dysferlin
* STRC
* OTOF

see also other cell membrane protein disorders

* v
* t
* e

Surface antigens

Major histocompatibility complex/
Human leukocyte antigen|

| MHC class I|

* HLA-A
* HLA-B
* HLA-C
* HLA-E
* HLA-F
* HLA-G

|

MHC class II|

* HLA-DM
* α
* β
* HLA-DO
* α
* β
* HLA-DP
* α1
* β1
* HLA-DQ
* α1
* α2
* β1
* β2
* β3
* HLA-DR
* α
* β1
* β3
* β4
* β5

* Minor histocompatibility antigen

Other|

* Arrestin
* Calgranulin
* Blood group antigens
* Cell adhesion molecules
* Differentiation antigens

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template